Clinical Trials Imaging Techniques Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

Clinical Trials Imaging Techniques Market Global Trends, Market Share, Industry
Size, Growth, Opportunities, and Market Forecast 2019 to 2026
Interpretable human physiology and anatomy information plays an important role in
both clinical and non-clinical trials for many years. Detecting, preventing and treating
various ailments often fosters healthcare trends. Clinical references in terms of
clinical imaging provide vital insights about drug effects. Hence clinical trial imaging
market is flourishing particularly when it comes to research and drug development
organisations. The global clinical trial imaging market is estimated to experience
profitable growth during the forecast period from 2019 to 2026 registering global
CAGR of 6.5%.
Potential upsurge in the number of pharma and biotechnology players, research
organizations, increase in aged population with chronic diseases along with
favourable R&D investments is expected to drive the growth clinical trial imaging
market during the forecast period.
Clinical Trails Imaging Market Drivers Overview:
1. Advancement in Imaging Technology
Numerous technology patents are being filled in an attempt to improve image
capturing and evaluation by core imaging labs in order to speed up the development
time for pharmaceutical organisations. Data accuracy, adaptability, consistency and
compliance to clinical studies is possible due to the latest image analysis software.
Advanced technology along with exceptional computation options enables rapid
improvements in collection, assessment and submission of clinical trial data.
2. Emerging Pharmaceutical and Biotechnology Industry
Medical imaging experiences fluctuations every now and then, yet numerous
pharmaceutical and biotechnology companies continue to emerge. Also increasing
investment in R&D for developing and discovering new drugs serves as a key driver in
clinical trials imaging market upthrust.
3. Mergers and Acquisitions
Not only investments in pharma and biotech firms but also the mergers and
acquisitions among medical imaging companies are forging ways to enhance clinical
trials imaging market.
4. High-Cost Imaging Systems and Implementation Barriers
Adoption of innovative imaging technologies to support clinical trials for medical
devices comes at a cost. Latest machinery, their installation, setting up mechanisms
to transfer scans to a central location incur a high cost as well as high capital required
to run clinical trials. Drug discoveries are augmenting the growth of clinical trials
which involves imaging guidance documentation, managing quality assurance,
performing quality control on scans received and the organization of independent
radiological review and/or image analysis involves experts who need to be paid.
These factors can restrain the growth of the market.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=109&page=requestsample
Clinical Trails Imaging Market Report Overview:
• Imaging Type Segment
o Computed Tomography (CT) Scan
o Magnetic Resonance Imaging (MRI)
o X-Ray
o Ultrasound
o Echocardiography
• End-Users
o Bio-Pharmaceutical companies
o Medical Devices Manufacturers
o Academic Institutes
o CROs i.e Contract Research Organizations
o Hospitals
o Others (cosmetics and skin care companies)
Purchase a Copy & Ask For Discount:
https://www.futurewiseresearch.com/requestsample.aspx?id=109&page=askfordiscount
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on global clinical trials imaging market by
imaging type, end-user and region
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Table of Contents
1. Introduction
1.1. Scope and Objective
1.2. Assumptions and Acronyms
1.3. Forecast Factors
1.4. Research Methodology
2. Executive Summary
2.1. Industry Cluster Analysis
2.2. Competition Matrix
2.3. Strategies Recommendations
3. Market Definition
3.1. Report Scope (Inclusions & Exclusions)
3.2. Market Segmentation
4. Global Clinical Trials Imaging Techniques Market Overview
4.1. Global Clinical Trials Imaging Techniques Market Revenue (USD Mn)
5. Key Inclusions
5.1. Porter’s Five Force analysis
5.2. Market Dynamics
5.3. Industry Trends
5.4. Regulatory Guidelines
5.5. Opportunities in Clinical Trials Imaging Techniques
6. Competition Dynamics
6.1. Company Share Analysis (2019)
6.2. Top 10 Product Pricing by Region
7. Global Clinical Trials Imaging Techniques Market Revenue (USD Mn), 20192026 by Imaging Type
7.1. Key Market Findings
7.2. Long Term ROI Segments
7.3. Revenue Opportunity Influencing Factors
7.4. Market Revenue (USD Mn) Assessment and Forecast by Imaging Type, 20192026
7.4.1
CT
7.4.2
MRI
7.4.3
PET
7.4.4
Ultrasound
7.4.5
Echocardiography
7.4.6 X-Ray
8. Global Clinical Trials Imaging Techniques Market Revenue (USD Mn), 2019-2026
by End User
8.1. Key Market Findings
8.2. Long Term ROI Segments
8.3. Revenue Opportunity Influencing Factors
8.4. Market Revenue (USD Mn) Assessment and Forecast by End User, 2019-2026
8.4.1
BiopharmaceuticalCompanies
8.4.2
ContractResearch Organization
8.4.3
AcademicInstitutes
8.4.4
Hospitals
8.4.5
Medical DeviceManufactures
8.4.6
AcademicInstitutes
9. Global Clinical Trials Imaging Techniques Market Revenue (USD Mn), 2019-2026
by Region
9.1. Key Market Findings
9.2. Long Term ROI Segments
9.3. Revenue Opportunity Influencing Factors
9.4. Market Revenue (USD Mn) Assessment and Forecast by Region,2026
9.4.1
North America
9.4.2 Latin America
9.4.3 Europe
9.4.4 Asia Pacific
9.4.5 Rest of world
10. North America Clinical Trials Imaging Techniques Market Revenue (US$ Mn),
2019-2026
10.1. Key Market Findings
10.2. Long Term ROI Segments
10.3. Revenue Opportunity Influencing Factors
10.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2019-2026
10.4.1 US
10.4.2 Canada
10.5. Market Revenue (USD Mn) Assessment and Forecast by Imaging
Type, 2019-2026
10.5.3 CT
10.5.4 MRI
10.5.5 PET
10.5.6 Ultrasound
10.5.7 Echocardiography
10.5.8 X-Ray
10.6. Market Revenue (USD Mn) Assessment and Forecast by End User,
2019-2026
10.6.9 Biopharmaceutical Companies
10.6.10 Contract Research Organization
10.6.11 Academic Institutes
10.6.12 Hospitals
10.6.13 Medical Device Manufactures
10.6.14 Academic Institutes
11. Latin America Clinical Trials Imaging Techniques Market Revenue (US$ Mn),
2019-2026
11.1. Key Market Findings
11.2. Long Term ROI Segments
11.3. Revenue Opportunity Influencing Factors
11.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2019-2026
11.4.1 Brazil
11.4.2 Mexico
11.4.3 Argentina
11.4.4 Rest of Latin America
11.5. Market Revenue (USD Mn) Assessment and Forecast by Imaging
Type, 2019-2026
11.5.5 CT
11.5.6 MRI
11.5.7 PET
11.5.8 Ultrasound
11.5.9 Echocardiography
11.5.10X-Ray
11.6. Market Revenue (USD Mn) Assessment and Forecast by End User,
2019-2026
11.6.11Biopharmaceutical Companies
11.6.12 Contract Research Organization
11.6.13 Academic Institutes
11.6.14 Hospitals
11.6.15 Medical Device Manufactures
11.6.16 Academic Institutes
12. Europe America Clinical Trials Imaging Techniques Market Revenue (US$ Mn),
2019-2026
12.1. Key Market Findings
12.2. Long Term ROI Segments
12.3. Revenue Opportunity Influencing Factors
12.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2019-2026
12.4.1 Germany
12.4.2 France
12.4.3 Spain
12.4.4 UK
12.4.5 Russia
12.4.6 Poland
12.4.7 Rest of Europe
12.5. Market Revenue (USD Mn) Assessment and Forecast by Imaging
Type, 2019-2026
12.5.8 CT
12.5.9 MRI
12.5.10PET
12.5.11Ultrasound
12.5.12Echocardiography
12.5.13X-Ray
12.6. Market Revenue (USD Mn) Assessment and Forecast by End User,
2019-2026
12.6.14Biopharmaceutical Companies
12.6.15 Contract Research Organization
12.6.16 Academic Institutes
12.6.17 Hospitals
12.6.18 Medical Device Manufactures
12.6.19 Academic Institutes
13. Asia Pacific America Clinical Trials Imaging Techniques Market Revenue (US$
Mn), 2019-2026
13.1. Key Market Findings
13.2. Long Term ROI Segments
13.3. Revenue Opportunity Influencing Factors
13.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2019-2026
13.4.1 Emerging Asia
13.4.1.1
China
13.4.1.2
India
13.4.1.3
ASEAN-5
13.4.1.4
Rest of Emerging Asia
13.4.2 Japan
13.5. Market Revenue (USD Mn) Assessment and Forecast by Imaging
Type, 2019-2026
13.5.3 CT
13.5.4 MRI
13.5.5 PET
13.5.6 Ultrasound
13.5.7 Echocardiography
13.5.8 X-Ray
13.6. Market Revenue (USD Mn) Assessment and Forecast by End User,
2019-2026
13.6.9 Biopharmaceutical Companies
13.6.10 Contract Research Organization
13.6.11 Academic Institutes
13.6.12 Hospitals
13.6.13 Medical Device Manufactures
13.6.14 Academic Institutes
14. Rest of World America Clinical Trials Imaging Techniques Market Revenue (US$
Mn), 2019-2026
14.1. Key Market Findings
14.2. Long Term ROI Segments
14.3. Revenue Opportunity Influencing Factors
14.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2019-2026
14.4.1 Middle East
14.4.2 South Africa
14.4.3 North Africa
14.4.4 Rest of World
14.5. Market Revenue (USD Mn) Assessment and Forecast by Imaging
Type, 2019-2026
14.5.5 CT
14.5.6 MRI
14.5.7 PET
14.5.8 Ultrasound
14.5.9 Echocardiography
14.5.10X-Ray
14.6. Market Revenue (USD Mn) Assessment and Forecast by End User,
2019-2026
14.6.11Biopharmaceutical Companies
14.6.12 Contract Research Organization
14.6.13 Academic Institutes
14.6.14 Hospitals
14.6.15 Medical Device Manufactures
14.6.16 Academic Institutes
15. Company Profiles
15.1. Competition Landscape
15.2. Global Company Share (USD Mn) Overview, 2019
15.3. Company Profiles
15.3.1 GE Healthcare
15.3.1.1
Corporate Overview
15.3.1.2
Financial Performance
15.3.1.3
Peer Comparison & 3C marketing equation
15.3.1.4
Company Strategy & Channel Management
15.3.2 Siemens Healthcare
15.3.2.1
Corporate Overview
15.3.2.2
Financial Performance
15.3.2.3
Peer Comparison & 3C marketing equation
15.3.2.4
Company Strategy & Channel Management
15.3.3 Philips Healthcare
15.3.3.1
Corporate Overview
15.3.3.2
Financial Performance
15.3.3.3
Peer Comparison & 3C marketing equation
15.3.3.4
Company Strategy & Channel Management
15.3.4 Shimadzu Corporation
15.3.4.1
Corporate Overview
15.3.4.2
Financial Performance
15.3.4.3
Peer Comparison & 3C marketing equation
15.3.4.4
Company Strategy & Channel Management
15.3.5 Toshiba Medical Systems Corporation
15.3.5.1
Corporate Overview
15.3.5.2
Financial Performance
15.3.5.3
Peer Comparison & 3C marketing equation
15.3.5.4
Company Strategy & Channel Management
15.3.6 Carestream Health
15.3.6.1
Corporate Overview
15.3.6.2
Financial Performance
15.3.6.3
Peer Comparison & 3C marketing equation
15.3.6.4
Company Strategy & Channel Management
15.3.7 Hitachi Medical Corporation
15.3.7.1
Corporate Overview
15.3.7.2
Financial Performance
15.3.7.3
Peer Comparison & 3C marketing equation
15.3.7.4
Company Strategy & Channel Management
15.3.7.5
16. Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com

Interpretable human physiology and anatomy information plays an important role in both clinical and non-clinical trials for many years. Detecting, preventing and treating various ailments often fosters healthcare trends. Clinical references in terms of clinical imaging provide vital insights about drug effects.

Download Report